Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine wipes to prevent neonatal and maternal infections
NCT00136370Phase 3Unknown
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of chlorhexidine in neonatal sepsis and puerperal infection (2 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoints: Rates of culture-confirmed or clinical neonatal sepsis and Rate of vertical transmission of colonization with group B streptococcus (GBS). Status: unknown.
02
Drugs
chlorhexidine
03
Conditions
neonatal sepsispuerperal infection
Beyond the preview
Go deeper on NCT00136370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136370.